nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Risedronate—PTGS2—thyroid cancer	0.00766	1	CrCbGaD
Ibandronate—Arthropathy—Doxorubicin—thyroid cancer	0.00222	0.00224	CcSEcCtD
Ibandronate—Pruritus—Vandetanib—thyroid cancer	0.00221	0.00223	CcSEcCtD
Ibandronate—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00221	0.00223	CcSEcCtD
Ibandronate—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00221	0.00223	CcSEcCtD
Ibandronate—Arthralgia—Sorafenib—thyroid cancer	0.0022	0.00222	CcSEcCtD
Ibandronate—Myalgia—Sorafenib—thyroid cancer	0.0022	0.00222	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00219	0.0022	CcSEcCtD
Ibandronate—Vaginal inflammation—Epirubicin—thyroid cancer	0.00219	0.0022	CcSEcCtD
Ibandronate—Injection site reaction—Epirubicin—thyroid cancer	0.00217	0.00219	CcSEcCtD
Ibandronate—Dry mouth—Sorafenib—thyroid cancer	0.00215	0.00217	CcSEcCtD
Ibandronate—Diarrhoea—Vandetanib—thyroid cancer	0.00214	0.00216	CcSEcCtD
Ibandronate—Ulcer—Doxorubicin—thyroid cancer	0.00214	0.00215	CcSEcCtD
Ibandronate—Cystitis noninfective—Epirubicin—thyroid cancer	0.00214	0.00215	CcSEcCtD
Ibandronate—Creatinine increased—Doxorubicin—thyroid cancer	0.00212	0.00214	CcSEcCtD
Ibandronate—Influenza like illness—Epirubicin—thyroid cancer	0.00212	0.00214	CcSEcCtD
Ibandronate—Bone pain—Doxorubicin—thyroid cancer	0.00211	0.00213	CcSEcCtD
Ibandronate—Cystitis—Epirubicin—thyroid cancer	0.00211	0.00213	CcSEcCtD
Ibandronate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00211	0.00213	CcSEcCtD
Ibandronate—Infection—Sorafenib—thyroid cancer	0.0021	0.00211	CcSEcCtD
Ibandronate—Candida infection—Epirubicin—thyroid cancer	0.00209	0.0021	CcSEcCtD
Ibandronate—Inflammation—Doxorubicin—thyroid cancer	0.00209	0.0021	CcSEcCtD
Ibandronate—Shock—Sorafenib—thyroid cancer	0.00208	0.00209	CcSEcCtD
Ibandronate—Nervous system disorder—Sorafenib—thyroid cancer	0.00207	0.00209	CcSEcCtD
Ibandronate—Dizziness—Vandetanib—thyroid cancer	0.00207	0.00208	CcSEcCtD
Ibandronate—Vaginal infection—Epirubicin—thyroid cancer	0.00206	0.00208	CcSEcCtD
Ibandronate—Skin disorder—Sorafenib—thyroid cancer	0.00205	0.00207	CcSEcCtD
Ibandronate—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00205	0.00206	CcSEcCtD
Ibandronate—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00202	0.00204	CcSEcCtD
Ibandronate—Injection site reaction—Doxorubicin—thyroid cancer	0.00201	0.00203	CcSEcCtD
Ibandronate—Oesophagitis—Epirubicin—thyroid cancer	0.002	0.00201	CcSEcCtD
Ibandronate—Vomiting—Vandetanib—thyroid cancer	0.00199	0.002	CcSEcCtD
Ibandronate—Mouth ulceration—Epirubicin—thyroid cancer	0.00198	0.00199	CcSEcCtD
Ibandronate—Bladder pain—Epirubicin—thyroid cancer	0.00198	0.00199	CcSEcCtD
Ibandronate—Ecchymosis—Epirubicin—thyroid cancer	0.00198	0.00199	CcSEcCtD
Ibandronate—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00198	0.00199	CcSEcCtD
Ibandronate—Rash—Vandetanib—thyroid cancer	0.00197	0.00199	CcSEcCtD
Ibandronate—Dermatitis—Vandetanib—thyroid cancer	0.00197	0.00199	CcSEcCtD
Ibandronate—Influenza like illness—Doxorubicin—thyroid cancer	0.00196	0.00198	CcSEcCtD
Ibandronate—Headache—Vandetanib—thyroid cancer	0.00196	0.00197	CcSEcCtD
Ibandronate—Cystitis—Doxorubicin—thyroid cancer	0.00195	0.00197	CcSEcCtD
Ibandronate—Pulmonary oedema—Epirubicin—thyroid cancer	0.00195	0.00196	CcSEcCtD
Ibandronate—Candida infection—Doxorubicin—thyroid cancer	0.00193	0.00195	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00192	0.00194	CcSEcCtD
Ibandronate—Hypertonia—Epirubicin—thyroid cancer	0.00192	0.00193	CcSEcCtD
Ibandronate—Vaginal infection—Doxorubicin—thyroid cancer	0.00191	0.00192	CcSEcCtD
Ibandronate—Nausea—Vandetanib—thyroid cancer	0.00186	0.00187	CcSEcCtD
Ibandronate—Dyspepsia—Sorafenib—thyroid cancer	0.00186	0.00187	CcSEcCtD
Ibandronate—Oesophagitis—Doxorubicin—thyroid cancer	0.00185	0.00186	CcSEcCtD
Ibandronate—Decreased appetite—Sorafenib—thyroid cancer	0.00183	0.00185	CcSEcCtD
Ibandronate—Mouth ulceration—Doxorubicin—thyroid cancer	0.00183	0.00184	CcSEcCtD
Ibandronate—Bladder pain—Doxorubicin—thyroid cancer	0.00183	0.00184	CcSEcCtD
Ibandronate—Ecchymosis—Doxorubicin—thyroid cancer	0.00183	0.00184	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00182	0.00184	CcSEcCtD
Ibandronate—Fatigue—Sorafenib—thyroid cancer	0.00182	0.00183	CcSEcCtD
Ibandronate—Constipation—Sorafenib—thyroid cancer	0.0018	0.00182	CcSEcCtD
Ibandronate—Pain—Sorafenib—thyroid cancer	0.0018	0.00182	CcSEcCtD
Ibandronate—Pulmonary oedema—Doxorubicin—thyroid cancer	0.0018	0.00181	CcSEcCtD
Ibandronate—Hypertonia—Doxorubicin—thyroid cancer	0.00177	0.00179	CcSEcCtD
Ibandronate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00173	0.00174	CcSEcCtD
Ibandronate—Renal failure acute—Epirubicin—thyroid cancer	0.00172	0.00173	CcSEcCtD
Ibandronate—Urticaria—Sorafenib—thyroid cancer	0.00168	0.00169	CcSEcCtD
Ibandronate—Body temperature increased—Sorafenib—thyroid cancer	0.00167	0.00168	CcSEcCtD
Ibandronate—Abdominal pain—Sorafenib—thyroid cancer	0.00167	0.00168	CcSEcCtD
Ibandronate—Renal impairment—Epirubicin—thyroid cancer	0.00167	0.00168	CcSEcCtD
Ibandronate—Renal failure acute—Doxorubicin—thyroid cancer	0.00159	0.0016	CcSEcCtD
Ibandronate—Pain in extremity—Epirubicin—thyroid cancer	0.00159	0.0016	CcSEcCtD
Ibandronate—Osteoarthritis—Epirubicin—thyroid cancer	0.00159	0.0016	CcSEcCtD
Ibandronate—Migraine—Epirubicin—thyroid cancer	0.00156	0.00157	CcSEcCtD
Ibandronate—Hypersensitivity—Sorafenib—thyroid cancer	0.00155	0.00157	CcSEcCtD
Ibandronate—Renal impairment—Doxorubicin—thyroid cancer	0.00154	0.00155	CcSEcCtD
Ibandronate—Face oedema—Epirubicin—thyroid cancer	0.00153	0.00154	CcSEcCtD
Ibandronate—Asthenia—Sorafenib—thyroid cancer	0.00151	0.00153	CcSEcCtD
Ibandronate—Pruritus—Sorafenib—thyroid cancer	0.00149	0.0015	CcSEcCtD
Ibandronate—Blood creatinine increased—Epirubicin—thyroid cancer	0.00149	0.0015	CcSEcCtD
Ibandronate—Pain in extremity—Doxorubicin—thyroid cancer	0.00147	0.00148	CcSEcCtD
Ibandronate—Osteoarthritis—Doxorubicin—thyroid cancer	0.00147	0.00148	CcSEcCtD
Ibandronate—Abdominal pain upper—Epirubicin—thyroid cancer	0.00145	0.00146	CcSEcCtD
Ibandronate—Migraine—Doxorubicin—thyroid cancer	0.00145	0.00146	CcSEcCtD
Ibandronate—Diarrhoea—Sorafenib—thyroid cancer	0.00144	0.00146	CcSEcCtD
Ibandronate—Breast disorder—Epirubicin—thyroid cancer	0.00143	0.00144	CcSEcCtD
Ibandronate—Nasopharyngitis—Epirubicin—thyroid cancer	0.00142	0.00143	CcSEcCtD
Ibandronate—Face oedema—Doxorubicin—thyroid cancer	0.00142	0.00143	CcSEcCtD
Ibandronate—Gastritis—Epirubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Ibandronate—Dizziness—Sorafenib—thyroid cancer	0.0014	0.00141	CcSEcCtD
Ibandronate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00138	0.00139	CcSEcCtD
Ibandronate—Asthma—Epirubicin—thyroid cancer	0.00137	0.00138	CcSEcCtD
Ibandronate—Influenza—Epirubicin—thyroid cancer	0.00137	0.00138	CcSEcCtD
Ibandronate—Dysphagia—Epirubicin—thyroid cancer	0.00137	0.00138	CcSEcCtD
Ibandronate—Vomiting—Sorafenib—thyroid cancer	0.00134	0.00135	CcSEcCtD
Ibandronate—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00134	0.00135	CcSEcCtD
Ibandronate—Rash—Sorafenib—thyroid cancer	0.00133	0.00134	CcSEcCtD
Ibandronate—Dermatitis—Sorafenib—thyroid cancer	0.00133	0.00134	CcSEcCtD
Ibandronate—Breast disorder—Doxorubicin—thyroid cancer	0.00133	0.00134	CcSEcCtD
Ibandronate—Headache—Sorafenib—thyroid cancer	0.00132	0.00133	CcSEcCtD
Ibandronate—Bronchitis—Epirubicin—thyroid cancer	0.00132	0.00133	CcSEcCtD
Ibandronate—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00131	0.00132	CcSEcCtD
Ibandronate—Gastritis—Doxorubicin—thyroid cancer	0.0013	0.00131	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—thyroid cancer	0.00127	0.00128	CcSEcCtD
Ibandronate—Nausea—Sorafenib—thyroid cancer	0.00125	0.00126	CcSEcCtD
Ibandronate—Weight decreased—Epirubicin—thyroid cancer	0.00124	0.00125	CcSEcCtD
Ibandronate—Pneumonia—Epirubicin—thyroid cancer	0.00123	0.00124	CcSEcCtD
Ibandronate—Infestation NOS—Epirubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Ibandronate—Infestation—Epirubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—thyroid cancer	0.00122	0.00123	CcSEcCtD
Ibandronate—Renal failure—Epirubicin—thyroid cancer	0.0012	0.00121	CcSEcCtD
Ibandronate—Stomatitis—Epirubicin—thyroid cancer	0.00119	0.0012	CcSEcCtD
Ibandronate—Urinary tract infection—Epirubicin—thyroid cancer	0.00119	0.0012	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00118	0.00119	CcSEcCtD
Ibandronate—Sweating—Epirubicin—thyroid cancer	0.00117	0.00118	CcSEcCtD
Ibandronate—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00116	0.00117	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—thyroid cancer	0.00115	0.00116	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—thyroid cancer	0.00111	0.00112	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—thyroid cancer	0.00109	0.0011	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—thyroid cancer	0.00108	0.00109	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—thyroid cancer	0.00108	0.00109	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—thyroid cancer	0.00108	0.00109	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—thyroid cancer	0.00108	0.00109	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00107	0.00108	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—thyroid cancer	0.00102	0.00103	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—thyroid cancer	0.00102	0.00103	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.001	0.00101	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—thyroid cancer	0.001	0.00101	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000998	0.00101	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—thyroid cancer	0.000996	0.001	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—thyroid cancer	0.000996	0.001	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—thyroid cancer	0.000992	0.000999	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000989	0.000997	CcSEcCtD
Ibandronate—Chills—Epirubicin—thyroid cancer	0.000985	0.000993	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—thyroid cancer	0.00097	0.000978	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—thyroid cancer	0.000962	0.000969	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—thyroid cancer	0.000956	0.000963	CcSEcCtD
Ibandronate—Erythema—Epirubicin—thyroid cancer	0.000956	0.000963	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—thyroid cancer	0.000949	0.000957	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—thyroid cancer	0.000943	0.00095	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—thyroid cancer	0.000942	0.000949	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—thyroid cancer	0.000936	0.000943	CcSEcCtD
Ibandronate—Back pain—Epirubicin—thyroid cancer	0.000924	0.000931	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—thyroid cancer	0.000922	0.000929	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—thyroid cancer	0.000919	0.000926	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—thyroid cancer	0.000917	0.000925	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000915	0.000922	CcSEcCtD
Ibandronate—Chills—Doxorubicin—thyroid cancer	0.000911	0.000918	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—thyroid cancer	0.000898	0.000904	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—thyroid cancer	0.00089	0.000897	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000887	0.000893	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—thyroid cancer	0.000884	0.000891	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—thyroid cancer	0.000884	0.000891	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—thyroid cancer	0.000883	0.00089	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—thyroid cancer	0.000871	0.000878	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—thyroid cancer	0.000866	0.000873	CcSEcCtD
Ibandronate—Malaise—Epirubicin—thyroid cancer	0.000862	0.000868	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—thyroid cancer	0.000859	0.000865	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—thyroid cancer	0.000855	0.000862	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—thyroid cancer	0.00085	0.000857	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—thyroid cancer	0.000844	0.000851	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—thyroid cancer	0.000825	0.000831	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00082	0.000827	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—thyroid cancer	0.000817	0.000824	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—thyroid cancer	0.000814	0.00082	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—thyroid cancer	0.000814	0.00082	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—thyroid cancer	0.000814	0.00082	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—thyroid cancer	0.000811	0.000817	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000808	0.000814	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—thyroid cancer	0.000804	0.00081	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—thyroid cancer	0.000797	0.000804	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—thyroid cancer	0.000796	0.000802	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—thyroid cancer	0.000794	0.000801	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—thyroid cancer	0.000781	0.000787	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—thyroid cancer	0.00078	0.000786	CcSEcCtD
Ibandronate—Infection—Epirubicin—thyroid cancer	0.000775	0.000781	CcSEcCtD
Ibandronate—Shock—Epirubicin—thyroid cancer	0.000767	0.000773	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—thyroid cancer	0.000765	0.000771	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—thyroid cancer	0.000763	0.000769	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—thyroid cancer	0.000758	0.000763	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000754	0.00076	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—thyroid cancer	0.000753	0.000759	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—thyroid cancer	0.000753	0.000759	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—thyroid cancer	0.000753	0.000759	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—thyroid cancer	0.00075	0.000756	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000748	0.000753	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—thyroid cancer	0.000744	0.000749	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—thyroid cancer	0.000736	0.000742	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000722	0.000727	CcSEcCtD
Ibandronate—Infection—Doxorubicin—thyroid cancer	0.000717	0.000722	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000711	0.000716	CcSEcCtD
Ibandronate—Shock—Doxorubicin—thyroid cancer	0.00071	0.000715	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000708	0.000713	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—thyroid cancer	0.000705	0.000711	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—thyroid cancer	0.000701	0.000706	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—thyroid cancer	0.0007	0.000706	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000698	0.000703	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—thyroid cancer	0.000687	0.000692	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—thyroid cancer	0.000678	0.000683	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000673	0.000679	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—thyroid cancer	0.000672	0.000678	CcSEcCtD
Ibandronate—Constipation—Epirubicin—thyroid cancer	0.000667	0.000672	CcSEcCtD
Ibandronate—Pain—Epirubicin—thyroid cancer	0.000667	0.000672	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000657	0.000663	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—thyroid cancer	0.000653	0.000658	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—thyroid cancer	0.000648	0.000653	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—thyroid cancer	0.000643	0.000648	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000638	0.000643	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—thyroid cancer	0.000635	0.00064	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—thyroid cancer	0.000627	0.000632	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000623	0.000628	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—thyroid cancer	0.000622	0.000627	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—thyroid cancer	0.00062	0.000624	CcSEcCtD
Ibandronate—Pain—Doxorubicin—thyroid cancer	0.000617	0.000622	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—thyroid cancer	0.000617	0.000622	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—thyroid cancer	0.000617	0.000621	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—thyroid cancer	0.000617	0.000621	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000595	0.000599	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00059	0.000595	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—thyroid cancer	0.000575	0.000579	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—thyroid cancer	0.000573	0.000578	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—thyroid cancer	0.00057	0.000575	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—thyroid cancer	0.00057	0.000575	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—thyroid cancer	0.00056	0.000564	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—thyroid cancer	0.000552	0.000556	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—thyroid cancer	0.000534	0.000538	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000532	0.000536	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—thyroid cancer	0.000518	0.000522	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—thyroid cancer	0.000516	0.00052	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—thyroid cancer	0.000511	0.000514	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—thyroid cancer	0.000496	0.0005	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—thyroid cancer	0.000494	0.000498	CcSEcCtD
Ibandronate—Rash—Epirubicin—thyroid cancer	0.000492	0.000496	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—thyroid cancer	0.000491	0.000495	CcSEcCtD
Ibandronate—Headache—Epirubicin—thyroid cancer	0.000489	0.000492	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—thyroid cancer	0.000477	0.000481	CcSEcCtD
Ibandronate—Nausea—Epirubicin—thyroid cancer	0.000463	0.000467	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—thyroid cancer	0.000459	0.000462	CcSEcCtD
Ibandronate—Rash—Doxorubicin—thyroid cancer	0.000455	0.000459	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—thyroid cancer	0.000455	0.000458	CcSEcCtD
Ibandronate—Headache—Doxorubicin—thyroid cancer	0.000452	0.000456	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—thyroid cancer	0.000429	0.000432	CcSEcCtD
